Cite

HARVARD Citation

    Ruotolo, G. et al. (n.d.). Effects of tirzepatide, a novel dual GIP and GLP-1 receptor agonist, on lipid profiling in patients with type 2 diabetes. European heart journal. p. . [Online]. 
  
Back to record